MORU Publications 1990 - 1999
(Excluding Abstracts)
174. Brewster DR, Kwiatkowski D, White NJ.Neurological sequelae of cerebral malaria in children. Lancet 1990;336:1039-1043.
175. Brown AE, Dance DAB, Chaowagul W, Webster HK, White NJ.Activation of cellular immune responses in melioidosis patients as assessed by urinary neopterin. Trans R Soc Trop Med Hyg 1990;84:583-584.
176. Dance DAB, Suputtamongkol Y, Chaowagul W, White NJ.Prophylaxis for contacts of melioidosis. J Infect 1990;21:222-223.
177. Dance DAB, White NJ, Suputtamongkol Y, Wattanagoon Y, Wuthiekanun V, Chaowagul W.The use of bone marrow culture for the diagnosis of melioidosis. Trans R Soc Trop Med Hyg 1990;84:585-587.
178. Dance DAB, White NJ, Suputtamongkol Y, Chaowagul W.Pseudomonas pseudomallei and sudden unexplained death in Thai construction workers. Lancet 1990;336:1257-1258.
179. Dance DAB.Melioidosis. Rev Med Microbiol 1990;1:143-150.
180. Davis TME, Karbwang J, Looareesuwan S, Turner RC, White NJ.Comparative effects of quinine and quinidine on glucose metabolism in healthy volunteers. Brit J Clin Pharmacol 1990;30:397-403.
181. Davis TME, Supanaranond W, Pukrittayakamee S, Karbwang J, Molunto P, Mekthon S, White NJ.A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis 1990;161:1305-1308.
182. Davis TME, Pukrittayakamee S, Supanaranond W, Looareesuwan S, Krishna S, Nagachinta B, Turner RC, White NJ.Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria. Clin Endocrinol (Oxf) 1990;33:739-749.
183. Davis TME, Supanaranond W, Pukrittayakamee S, Krishna S, Hart GR, Burrin JM, Looareesuwan S, Vilaiwanna N, White NJ.The pituitary-thyroid axis in severe falciparum malaria: evidence for depressed thyrotroph and thyroid gland function. Trans R Soc Trop Med Hyg 1990;84:330-335.
184. Davis TME, Krishna S, Looareesuwan S, Supanaranond W, Pukrittayakamee S, Attatamsoonthorn K, White NJ.Erythrocyte sequestration and anemia in severe falciparum malaria.Analysis of acute changes in venous hematocrit using a simple mathematical model. J Clin Invest 1990;86:793-800.
185. Editorial.Exchange transfusion in falciparum malaria. Lancet 1990;335:324-325.
186. Ho M, Webster HK, Tongtawe P, Pattanapanyasat K, Weidanz W.Increased g T cells in acute falciparum malaria. Immunol Let 1990;25:139-142.
187. Ho M, Silamut K, White NJ, Karbwang J, Looareesuwan S, Phillips RE, Warrell DA. Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand. Am J Trop Med Hyg 1990;42:260-266.
188. Ho M, White NJ, Looareesuwan S, Wattanagoon Y, Lee SH, Walport MJ, Bunnag D, Harinasuta T.Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J Infect Dis 1990;161:555-561.
189. Ho M, Webster HK.T-cell responses in acute falciparum malaria. Immunol Let 1990;25:135-138.
190. Hutton RA, Looareesuwan S, Ho M, Silamut K, Chanthavanich P, Karbwang J, Supanaranond W, Vejcho S, Viravan C, Phillips RE, Warrell DA.Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. Trans R Soc Trop Med Hyg 1990;84:866-874.
191. Karbwang J, White NJ.Clinical pharmacokinetics of mefloquine. Clin Pharmacokinet 1990;19:264-279.
192. Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature.Q J Med 1990;75:471-481.
193. Looareesuwan S, Charoenpan P, Ho M, White NJ, Karbwang J, Bunnag D, Harinasuta T.Fatal Plasmodium falciparum malaria after an inadequate response to quinine treatment.J Infect Dis 1990;161:577-580.
194. Nosten F, Karbwang J, White NJ, Honeymoon; Na Bangchang K, Bunnag D, Harinasuta T.Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study. Brit J Clin Pharmacol 1990;30:79-85.
195. Pukrittayakamee S, Nontprasert A, White NJ, Warrell DA, Bunnag D.Characterization of a monoclonal antibody that neutralizes the hyaluronidase activity of Russell's viper venom. S E Asian J Trop Med Publ Hlth 1990;21:231-237.
196. Pukrittayakamee S, Desakorn V, Clemens R, Nontprasert A, Bock HL, White NJ, Bunnag D.Synergy of antithrombin III concentrate and antivenom in preventing coagulopathy in a rat model of Malayan pit viper envenoming. Trans R Soc Trop Med Hyg 1990;84:880-884.
197. Roche RJ, Silamut K, Pukrittayakamee S, Looareesuwan S, Molunto P, Boonamrung S, White NJ.Quinine induces reversible high-tone hearing loss. Brit J Clin Pharmacol 1990;29:780-782.
198. Theakston RD, Phillips RE, Looareesuwan S, Echeverria P, Makin T, Warrell DA. Bacteriological studies of the venom and mouth cavities of wild Malayan pit vipers (Calloselasma rhodostoma) in southern Thailand. Trans R Soc Trop Med Hyg 1990;84:875-879.
199. Theakston RD, Phillips RE, Warrell DA, Galagedera Y, Abeysekera DT, Dissanayaka P, de Silva A, Aloysius DJ.Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans R Soc Trop Med Hyg 1990;84:301-308.
200. Waller D, Krishna S, Craddock C, Brewster D, Jammeh A, Kwiatkowski D, Karbwang J, Molunto P, White NJ.The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:488-491.
201. White NJ, Krishna S.Schizontocidal antimalarials: a reply.Trans R Soc Trop Med Hyg 1990;84:610.
202. World Health Organization, Division of Control of Tropical Diseases.Severe and complicated malaria.2nd ed.Trans R Soc Trop Med Hyg 1990;84 (suppl 2):1-65.
203. Wuthiekanun V, Dance DAB, Chaowagul W, Suputtamongkol Y, Wattanagoon Y, White NJ.Blood culture techniques for the diagnosis of melioidosis.Eur J Clin Microbiol Infect Dis 1990;9:654-658.
204. Wuthiekanun V, Dance DAB, Wattanagoon Y, Supputtamongkol Y, Chaowagul W, White NJ.The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice.J Med Microbiol 1990;33:121-126.
205. Brown AE, Dance DAB, Suputtamongkol Y, Chaowagul W, Kongchareon S, Webster HK, White NJ.Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble
interleukin-2 receptors without change in soluble CD8 protein.J Infect Dis 1991;163:1145-1148.
206. Chittichai P, Chierakul N, Davis TME.Peripheral gangrene in nonfatal paediatric cerebral malaria: a report of two cases. S E Asian J Trop Med Publ Hlth 1991;22:190-194.
207. Dance DAB, Wuthiekanun V, Chaowagul W, Suputtamongkol Y, White NJ. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei. J Antimicrob Chemother 1991;28:321-324.
208. Dance DAB. Pseudomonas pseudomallei : danger in the paddy fields. Trans R Soc Trop Med Hyg 1991;85:1-3.
209. Dance DAB.Melioidosis: the tip of the Iceberg. Clin Microbiol Rev 1991;4:52-60.
210. Davis TME, Pukrittayakamee S, Woodhead JS, Holloway P, Chaivisuth B, White NJ. Calcium and phosphate metabolism in acute falciparum malaria.Clin Sci 1991;81:297-304.
211. Davis TME, Ho M, Supanaranond W, Looareesuwan S, Pukrittayakamee S, White NJ. Changes in the peripheral blood eosinophil count in falciparum malaria. Acta Trop (Basel) 1991;48:243-246.
212. Godfrey AJ, Wong S, Dance DAB, Chaowagul W, Bryan LE.Pseudomonas
pseudomallei resistance to B-lactam antibiotics due to alterations in the chromosomally encoded B-lactamase. Antimicrob Agents Chemother 1991;35:1635-1640.
213. Ho M, Davis TME, Silamut K, Bunnag D, White NJ.Rosette formation of Plasmodium falciparum -infected erythrocytes from patients with acute malaria. Infect Immun 1991;59:2135-2139.
214. Ho M, Singh B, Looareesuwan S, Davis TME, Bunnag D, White NJ.Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun 1991;59:873-878.
215. Holloway PA, Krishna S, White NJ. Plasmodium berghei: lactic acidosis and hypoglycaemia in a rodent model of severe malaria; effects of glucose, quinine, and dichloroacetate. Exp Parasitol 1991;72:123-133.
216. Johnson JR, Lyons MF, Pearce W, Gorman P, Roberts PL, White NJ, Brust P, Olsen R, Gnann JWJ, Stamm WE.Therapy for women hospitalised with acute pyelonephritis: a randomised trial of ampicillin vs trimethoprim-sulphamethoxazole for 14 days. J Infect Dis 1991;163:325-330.
217. Looareesuwan S, Davis TME, Pukrittayakamee S, Supanaranond W, Desakorn V, Silamut K, Krishna S, Boonamrung S, White NJ.Erythrocyte survival in severe falciparum malaria.Acta Trop (Basel) 1991;48:263-270.
218. Luxemburger C, Nosten F, ter Kuile F, Frejacques L, Chongsuphajaisiddhi T, White NJ. Mefloquine for multidrug-resistant malaria. Lancet 1991;338:1268.
219. Nosten F, ter Kuile F, Maelankirri L, Decludt B, White NJ.Malaria during pregnancy in an area of unstable endemicity. Trans R Soc Trop Med Hyg 1991;85:424-429.
220. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na Bangchang K, Karbwang J, White NJ. Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Brit J Clin Pharmacol 1991;31:556-559.
221. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ.Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991;337:1140-1143.
222. Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, Jamieson GA, Chulay JD, Webster HK.Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991;164:163-169.
223. Pukrittayakamee S, Davis TME, Levy J, Looareesuwan S, Roche RJ, Jeerawathanapun P, White NJ.The metabolic response to rapid intravenous glucose injection in acute falciparum malaria. Trans R Soc Trop Med Hyg 1991;85:189-193.
224. Pukrittayakamee S, Clemens R.Coagulation abnormalities in falciparum malaria. Biomedical Progress 1991;4:21-23.
225. Silamut K, Molunto P, Ho M, Davis TME, White NJ.Alpha 1-acid glycoprotein
(orosomucoid) and plasma protein binding of quinine in falciparum malaria. Brit J Clin Pharmacol 1991;32:311-315.
226. Siripanthong S, Teerapantuwat S, Prugsanusak W, Suputtamongkol Y, Viriyasithavat P, Chaowagul W, Dance DA, White NJ.Corneal ulcer caused by Pseudomonas pseudomallei: report of three cases. Rev Infect Dis 1991;13:335-337.
227. Smith CJ, Jones M, Dance DAB, White NJ, Chaowagul W.Diagnosis of melioidosis by means of an ELISA detecting antibodies to Pseudomonas pseudomallei exotoxin. Preliminary assay evaluation. Wld J Microbio Biotech 1991;7:29-36.
228. Stamm WE, McKevitt M, Roberts PL, White NJ.Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991;13:77-84.
229. Supanaranond W, Davis TME, Pukrittayakamee S, Silamut K, Karbwang J, Molunto P, Chanond L, White NJ.Disposition of oral quinine in acute falciparum malaria. Eur J Clin Pharmacol 1991;40:49-52.
230. Suputtamongkol Y, Dance DAB, Chaowagul W, Wattanagoon Y, Wuthiekanun V, White NJ.Amoxycillin-clavulanic acid treatment of melioidosis. Trans R Soc Trop Med Hyg 1991;85:672-675.
231. Thein Than, Tin Tun, Hla Pe, Phillips RE, Myint Lwin, Tin Nu Swe, Warrell DA. Development of renal function abnormalities following bites by Russell's vipers (Daboia russelii siamensis) in Myanmar. Trans R Soc Trop Med Hyg 1991;85:404-409.
232. Waller D, Crawley J, Nosten F, Chapman D, Krishna S, Craddock C, Brewster D, White NJ.Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg 1991;85:362-364.
233. White NJ.The clinical evaluation of antimalarial treatment responses.Acta Leidensia 1991;60:141-146.
234. White NJ.Lumbar puncture in cerebral malaria. Lancet 1991;338:640-641.
235. White NJ.Sulfadoxine-pyrimethamine for the treatment of malaria.Trans R Soc Trop Med Hyg 1991;85:556-557.
236. White NJ.Treatment and prophylaxis of falciparum malaria.J Antimicrob Chemother 1991;26:728-729.
237. White NJ, Plorde J.Malaria.In: Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JD, Fauci AS, eds. Harrison's Principles of Internal Medicine.New York: McGraw-Hill, 1991;782-788.
238. Dance DAB, Smith MD, Walsh M, Wuthiekanun V, White NJ.Melioidosis and laboratory safety.J Hosp Infect 1992;21:333-334.
239. Davis TME, Supanaranond W, Spencer JL, Ford S, Chienkul N, Shulenburg WE, White NJ.Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin Infect Dis 1992;15:256-266.
240. Editorial.Rediscovering wormwood, qinghaosu for malaria. Lancet 1992; 339: 649-651.
241. Editorial.QBC for malaria diagnosis. Lancet 1992;339:1022-1033.
242. Editorial.Desferrioxamine for cerebral malaria. Lancet 1992;340:1386-1387.
243. Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, White NJ, Griffin GE.Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992;60:2402-2408.
244. Ho M, Bannister LH, Looareesuwan S, Suntharasamai P.Cytoadherence and ultrastructure of Plasmodium falciparum-infected erythrocytes from a splenectomized patient. Infect Immun 1992;60:2225-2228.
245. Lorenz R, Vlizou M, Clemens R, Tornieporth N, Pukrittayakamee S.Russell's viper venom: effects on coagulating whole blood in vitro. Haemostasis 1992;22:153-159.
246. Looareesuwan S, Davis JG, Allen DL, Lee SH, Bunnag D, White NJ.Thrombocytopenia in malaria. S E Asian J Trop Med Publ Hlth 1992;23:44-50.
247. Pukrittayakamee S, White NJ, Davis TM, Looareesuwan S, Supanaranond W, Desakorn V, Chaivisuth B, Williamson DH.Hepatic blood flow and metabolism in severe falciparum malaria: clearance of intravenously administered galactose. Clin Sci 1992;82:63-70.
248. Pukrittayakamee S, Clemens R, Pramoolsinsap C, Karges HE, Vanijanonta S, Bunnag D, White NJ.Polymorphonuclear leukocyte elastase in Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1992;86:598-601.
249. Supanaranond W, Davis TME, Dawes J, Silamut K, Vilaiwanna N, White NJ.In-vivo platelet activation and anomalous thrombospondin levels in severe falciparum malaria. Platelets 1992;3:195-200.
250. Suputtamongkol Y, Kwiatkowski D, Dance DA, Chaowagul W, White NJ.Tumor necrosis factor in septicemic melioidosis.J Infect Dis 1992;165:561-564.
251. ter Kuile F, Nosten F, Chongsuphajaisiddhi T, Holloway P, Maelankirri L, White NJ. Absorption of intramuscular phenobarbitone in children with severe falciparum malaria. Eur J Clin Pharmacol 1992;42:107-110.
252. ter Kuile F, Nosten F, Thieren M, Luxemburger C, Edstein MD, Chongsuphajaisiddhi T, Phaipun L, Webster HK, White NJ.High dose mefloquine in the treatment of multi-drug resistant falciparum malaria. J Infect Dis 1992;166:1393-1400.
253. Vatcharapreechasakul T, Suputtamongkol Y, Dance DA, Chaowagul W, White NJ. Pseudomonas pseudomallei liver abscesses: a clinical, laboratory, and ultrasonographic study. Clin Infect Dis 1992;14:412-417.
254. Viravan C, Looareesuwan S, Kosakarn W, Wuthiekanun V, McCarthy CJ, Stimson AF, Bunnag D, Harinasuta T, Warrell DA.A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg 1992;86:100-106.
255. Warrell DA, Looareesuwan S, Stimson AF, Hutton RA.Rediscovery and redefinition ofMalcolm Smith's Trimeresurus kanburiensis in Thailand, with a report of envenoming.Trans R Soc Trop Med Hyg 1992;86:95-99.
256. White NJ, Waller D, Crawley J, Nosten F, Chapman D, Brewster D, Greenwood BM. Comparison of artemether and chloroquine for severe malaria in Gambian children. Lancet 1992;339:317-321.
257. White NJ, Chapman D, Watt G.The effects of multiplication and synchronicity on the vascular distribution of parasites in falciparum malaria. Trans R Soc Trop Med Hyg 1992; 86: 590-597.
258. White NJ, Ho M.The pathophysiology of malaria.In: Advances in Parasitology. Academic Press, 1992;84-175.
259. White NJ, Davis TME.Anti-infective drugs. In: van-Boxtall C, Holford NHG, Danhof M, eds.The in-vivo study of drug action: principles and applications of kinetic -dynamic modelling.Amsterdam: Elsevier, 1992;313-336.
260. White NJ.Antimalarial pharmacokinetics and treatment regimens. Brit J Clin Pharmacol 1992;34:1-10.
261. White NJ.Antimalarial drug resistance: the pace quickens.J Antimicrob Chemother 1992;30:571-585.
262. White NJ, Krishna S, Looareesuwan S.Encephalitis, not cerebral malaria, is likely cause of coma with negative blood smears.J Infect Dis 1992;166:1195-1196.
263. White NJ.Quinine for children with severe and complicated malaria.Trans R Soc Trop Med Hyg 1992;86:571-572.
264. Chaowagul W, Suputtamongkol Y, Dance DAB, Rajchanuvong A, Pattara-arechachai J, White NJ. Relapse in melioidosis: incidence and risk factors. J Infect Dis 1993;168:1181-1185.
265. Davis TME, Supanaranond W, Pukrittayakamee S, Chanond L, White NJ.Glucose
tolerance in pregnant patients with acute falciparum malaria. Trans R Soc Trop Med Hyg 1993;87:666-667.
266. Davis TME, Looareesuwan S, Pukrittayakamee S, Levy JC, Nagachinta B, White NJ. Glucose turnover in severe falciparum malaria. Metabolism 1993;42:334-340.
267. Desmarchelier PM, Dance DAB, Chaowagul W, Suputtamongkol Y, White NJ, Pitt TL. Relationships among Pseudomonas pseudomallei isolates frompatients with recurrent melioidosis.J Clin Microbiol 1993;31:1592-1596.
268. Dolan G, ter Kuile F, Jacoutot V, White NJ, Luxemburger C, Maelankiri L, Chongsuphajaisiddhi T, Nosten F.Bednets for the prevention of malaria and anaemia in pregnancy. Trans R Soc Trop Med Hyg 1993;87:620-626.
269. Edwards G, McGrath CS, Ward SA, Supanaranond W, Pukrittayakamee S, Davis TME, White NJ.Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Br J Clin Pharmacol 1993;35:193-198.
270. Friedland JS, Ho M, Remick DG, Bunnag D, White NJ, Griffin GE.Interleukin-8 and Plasmodium falciparum malaria in Thailand. Trans R Soc Trop Med Hyg 1993;87:54-55.
271. Kanaphun P, Thirawattasuk N, Suputtamongkol Y, Naigowit P, Dance DAB, Smith MD, White NJ.Serology and carriage of Pseudomonas pseudomallei : a prospective study in 1000 hospitalised children in north eastern Thailand. J Infect Dis 1993;167:230-233.
272. Karbwang J, Davis TME, Looareesuwan S, Molunto P, Bunnag D, White NJ.A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 1993;35:265-271.
273. Krishna S, ter Kuile F, Supanaranond W, Pukrittayakamee S, Teja-Isavadharm P, Kyle D, White NJ.Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria. Br J Clin Pharmacol 1993;36:585-591.
274. Krishna S, White NJ.Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria.Trans R Soc Trop Med Hyg 1993;87:436-443.
275. Looareesuwan S, Suntharasamai P, Webster HK, Ho M.Malaria in splenectomized patients: report of four cases and review.Clin Infect Dis 1993;16:361-366.
276. Nosten F, ter Kuile F, Thwai KL, Maelankiri L, White NJ.Spiramycin does not potentiate quinine treatment of falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 1993;87:305-306.
277. Nosten F, ter Kuile FO, Luxemburger C, Woodrow C, Kyle DE, Chongsuphajaisiddhi T, White NJ.Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341:1054-1056.
278. Sexton MM, Goebel LA, Godfrey AJ, Chaowagul W, White NJ, Woods DE.Ribotype analysis of Pseudomonas pseudomallei isolates. J Clin Micro 1993;31:238-243.
279. Silamut K, White NJ.Relation of the stage of parasite development in the peripheral
blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg 1993;87:436-443.
280. Smith MD, Wuthiekanun V, Walsh A, Pitt TL.Latex agglutination test for the identification of Pseudomonas pseudomallei. J Clin Pathol 1993;46:374-375.
281. Smithius FM, van Woensell JBM, Nordlander E, Vantha WS, ter Kuile FO.Comparison of two mefloquine regimens for the treatment of Plasmodium falciparum malaria on the north estern Thai-Cambodian border. Antimicrob Agents Chemother 1993;37:1977-1981.
282. Supanaranond W, Davis TME, Pukrittayakamee S, Nagachinta B, White NJ.Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs. Eur J Clin Pharmacol 1993;44:325-329.
283. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in-vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria.Exp Parasitol 1993;76:85-95.
284. ter Kuile FO, Nosten F, Luxemburger C, White NJ.Mefloquine prophylaxis. Lancet 1993;342:551.
285. ter Kuile FO, Dolan G, Nosten F, Edstein MD, Luxemburger C, Phaipun L, Chongsuphajaisiddhi T, Webster HK, White NJ.Halofantrine versus mefloquine in the treatment of multi-drug resistant falciparum malaria. Lancet 1993;341:1044-1049.
286. Wangboonskul J, White NJ, Nosten F, ter Kuile F, Moody RR, Taylor RB.Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 1993;44:247-251.
287. White NJ, Pukrittayakamee S.Clinical malaria in the tropics. Med J Aust 1993;159:197-203.
288. White NJ, Nosten F.Advances in chemotherapy and prophylaxis of malaria. Curr Opin Infect Dis 1993;6:323-330.
289. White NJ.The development of immunity to malaria.A clinical view. Asia Pacific J Immunol 1993;11:1-3.
290. White NJ. (Commentary).Malaria parasites go ape. Lancet 1993;341:793.
291. Bryan LE, Wong S, Woods DE, Dance DAB, Chaowagul W.Passiveprotection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis 1994;5:170-178.
292. Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Brit J Haematol 1994;87:100-105.
293. Davis TME, Suputtamongkol Y, Spancer JL, Wilson SG, Mekhton S, Croft KD, White NJ.Glucose turnover in pregnant women with acute malaria. Clin Sci 1994;86:83-90.
294. Desakorn V, Smith MD, Wuthiekanun V, Dance DAB, Aucken HM, Suntharasamai P, Rajchanuwong A, White NJ.Detection of Pseudomonas pseudomallei antigen in urine for the diagnosis of melioidosis. Am J Trop Med Hyg 1994;51:627-633.
295. Gotoh N, White NJ, Chaowagul W, Woods DE.Isolation and characterisation of the outer membrane proteins of Pseudomonas pseudomallei.Microbiology 1994;140:797-805.
296. Ho M, Tongtawe P, Kriangkum J, Wimonwattrawatee T, Pattanapanyasat K, Bryant L, Shafiq J, Suntharasamai P, Looareesuwan S, Webster HK, Elliott JF.Polyclonal expansion of peripheral T-cells in human Plasmodium falciparum malaria.Infect Immun 1994;62:855-862.
297. Krishna S, Supanaranond W, Pukrittayakamee S, Holloway PA, Karter D, Suputtamongkol Y, Davis TME, White NJ.Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metabolism 1994;43:974-981.
298. Krishna S, Waller DW, ter Kuile F, Kwiatkowski D, Crawley J, Craddock CF, Nosten F, Chapman D, Holloway PA, White NJ.Lactic acidosis and hypoglycaemia in children with severe malaria. Trans R Soc Trop Med Hyg 1994;88:67-73.
299. Luxemburger C, ter Kuile F, Nosten F, Dolan G, Bradol JH, Phaipun L, Chongsuphajaisiddhi T, White NJ.Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1994;88:213-217.
300. Na Bangchang K, Davis TME, Looareesuwan S, White NJ, Bunnag D, Karbwang J.Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria.Trans R Soc Trop Med Hyg 1994;88:321-323.
301. Nosten F, ter Kuile F, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, Boudreau E, Bunnag D, White NJ.Mefloquine prophylaxis prevents malaria during pregnancy: a double blind placebo controlled study. J Infect Dis 1994;169:595-603.
302. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Pa Eh J, Chongsuphajaisiddhi , White NJ.Treatment of multi-drug resistant Plasmodium falciparum with 3-day artesunate-mefloquine combination.J Infect Dis 1994;170:971-977.
303. Nosten F.Artemisinin: large community studies. Trans R Soc Trop Med Hyg 1994:88, Supplement1; 45-47.
304. Pukrittayakamee S, Viravan C, Charoenlarp P, Yeamput C, Wilson RJM, White NJ.Antimalarial effects of rifampin in Plasmodium vivax malaria. Antimicrob Agents Chemother 1994;38:511-514.
305. Pukrittayakamee S, Clemens R, Nonprasert A, Desakorn V, Charoenlarp P, Chongsuphajaisiddhi T, White NJ.Antithrombin III and antivenom reversal of coagulopathy in rats envenomated with Malayan pit viper venom. Toxicon 1994;32:97-103.
306. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ.Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 1994;169:932-935.
307. Pukrittayakamee S, Supanaranond W, Looareesuwan S, Vanijanonta S, White NJ. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg 1994;88:324-327.
308. Pukrittayakamee S, White NJ, Davis TME, Supanaranond W, Crawley J, Nagachinta B, Williamson DH.Glycerol metabolism in severe falciparum malaria. Metabolism 1994;43:887-892.
309. Smith MD, Wuthiekanun V, Walsh AL, White NJ.Susceptibility of Pseudomonas pseudomallei to some newer B-lactam antibiotics and antibiotic combinations using time-kill studies. J Antimicrob Chemother 1994;33:145-149.
310. Suputtamongkol Y, Rajchanuvong A, Chaowagul W, Dance DAB, Smith MD, Wuthiekanun V, Walsh AL, Pukrittayakamee S, White NJ.Ceftazidime versus coamoxiclav in the treatment of severe melioidosis. Clin Infect Dis 1994;19:846-853.
311. Suputtamongkol Y, Hall AJ, Dance DAB, Chaowagul W, Rajchanuvong A, Smith MD, White NJ.The epidemiology of melioidosis in Ubon Ratchatani, Northeast Thailand.Intl J Epidemiol 1994;23:1082-1090.
312. ter Kuile FO, Teja-Isavatharm, Edstein MD, Keeratithakul D, Dolan G, Nosten F, Phaipun L, Webster HK, White NJ.Comparison of capillary whole blood, venous whole blood, and plasma concentrations of mefloquine, halofantrine, and desbutyl halofantrine measured by high performance liquid chromatography. Am J Trop Med Hyg; 1994,51:778-784.
313. Turner GDH, Morrison H, Jones M, Davis TME, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukrittayakamee S, Nagachinta B, White NJ, Berendt AR.An immunohistochemical study of the pathology of fatal malaria: Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.Am J Pathol 1994;145:1057-1069.
314. Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Desakorn V, Chaowagul W, White NJ.Immunofluorescence microscopy for the rapid diagnosis of melioidosis. J Clin Pathol 1994;47:377-379.
315. Watt G, Smith CD, Kaewsupo A, Davis TME.3,4-Diaminopyridine reverses respiratory paralysis induced by a presynaptically active snake venom and its major neurotoxin.Trans R Soc Trop Med Hyg 1994;88:243-246.
316. Wattanagoon Y, Srivilairit S, Looareesuwan S, White NJ.Convulsions in childhood malaria. Trans R Soc Trop Med Hyg 1994;88:426-428.
317. White NJ, Breman JG.Malaria and babesiosis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds.Harrison's Principles of Internal Medicine. New York: McGraw-Hill, Inc., 1994;887-896.
318. White NJ (Editorial).Mefloquine. Br Med J 1994;308:286-287.
319. White NJ.Melioidosis. Zentral f Bakteriol 1994;280:439-443.
320. White NJ.Artemisinin: Current status Trans R Soc Trop Med Hyg 1994;88:Supplement1; 3-4.
321. White NJ.Clinical pharmacokinetics and pharmacodynamics of the artemisininderivatives. Trans R Soc Trop Med Hyg 1994:88: Supplement 1; 41-44.320.
322. White NJ.Tough test for malaria vaccine (Editorial). Lancet 1994:344:1172-3.
323. Ballou WR, Blood J, Wongsrichanalai C, Gordon DM, Heppner DG, Kyle DE,Luxemburger C, Nosten F, Singhasivanond P, Sadoff JC, Chongsuphajaisiddhi T, White NJ, Webster HK, Wittes J.Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPF66 in Thailand and the analytic plan for a phase IIb efficacy study. Parasitology 1995;110:(Suppl) S25-36.
324. Clemens R, Pukrittayakamee S, Nonprasert A, Bock HL, Vanijanonta S, Charoenlarp P, White NJ.Therapeutic effects of antivenom supplemented by antithrombin III in rats experimentally envenomated with Russell's viper (Daboia russelli siamensis) venom. Toxicon 1995;33:77-82.
325. Clemens R, Lorenz R, Pukrittayakamee S, Punpoowang B, Vanijanonta S, Charoenlarp P.Effects of antithrombin III and antivenom on procoagulant activity of Russell's viper venom in a whole blood model. SE Asian J Trop Med Publ Hlth 1995;26:143-148.
326. Davis TME, Pramukkul P, Suputtamongkol Y, Chaowagul W, Levy J.Glucose tolerance in rural diabetic Thais, first-degree relatives and non-diabetic controls. Diabetes Res (Clin Pract) 1995;27:171-180.
327. Davis TME, Supanaranond W, Pukrittayakamee S, Crawley JC, Vilaiwanna N, White NJ. The effect of plasma free fatty acids and long-chain triglycerides on glucose metabolism in uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:511-515.
328. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis 1995;172:838-844.
329. Holloway PA, Know K, Bajai N, Chapman D, White NJ, O'Brien R, Stacpoole PW, Krishna S.Plasmodium berghei infection: dichloroacetate improves survival in rats with lactic acidosis. Exp Parasitol 1995;80:624-632.
330. Jong EC, White NJ.Malaria prevention. In: Jong EC, McMullen R eds. The Travel and Tropical Medicine Manual. 2nd edition. Philadelphia: WB Saunders, 1995;50-64.
331. Krishna S, Agbenyega T, Angus BJ, Bedu-addo G, Ofori-amanfo G, Henderson G, Szwandt ISF, O'Brien R,Stacpoole PW.Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Q J Med 1995;88:341-349.
332. Krishna S, Pukrittayakamee S, Supanaranond W, ter Kuile F, Ruprah M, Sura T, White NJ.Fever in uncomplicated Plasmodium falciparum malaria: randomized double-blind comparison of ibuprofen and paracetamol treatment.Trans R Soc Trop Med Hyg 1995;89:507-509.
333. Krishna S, Supanaranond W, Pukrittayakamee S, ter Kuile F, Suputtamongkol Y, Attatamsoonthorn K, Ruprah M, White NJ.Fever in uncomplicated Plasmodium falciparum infection: effects of quinine and paracetamol. Trans R Soc Trop Med Hyg 1995;89:197-199.
334. Looareesuwan S, Wilairatana P, Krishna S, Kendall B, Vannaphon S, Viravan C, White NJ.Magnetic resonance imaging of the brain in cerebral malaria. Clin Infect Dis 1995;21:300-309.
335. Luxemburger C, Nosten F, Shotar RD, Chongsuphajaisiddhi T, White NJ.Oralartesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 1995;53:522-525.
336. Nosten F, Price RN.New Antimalarials (A Risk-Benefit Analysis). Drug Safety 1995;12:264-273.
337. Phung LV, Han Y, Oka S, Hotta H, Smith MD, Theeparakun P, Yabuuchi E, Yano I. Enzyme-linked immunosorbent assay (ELISA) using a glycolipid antigen for the serodiagnosis of melioidosis. FEMS Immunol Med Microbiol 1995;12:259-264.
338. Pied S, Tabone MD, Chatellier G, Marussig M, Jardel C, Nosten F, Mazier D. Non-specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. Parasite 1995; 2: 263-266.
339. Price RN, Nosten F, Luxemburger C, Am Kham, Brockman A, Chongsuphajaisiddhi T, White NJ.Artesunate versus artemether in combination with mefloquine for the treatment of multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:523-527.
340. Pukrittayakamee S, White NJ.New treatments for malaria. Postgraduate Doctor (Africa) 1995;17:14-18.
341. Pukrittayakamee S, White NJ.New treatments for malaria. Maternal Child Health 1995;20:28-33.
342. Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DAB, White NJ. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg 1995;89:546-549.
343. Silamut K, Hough R, Eggelte T, Pukrittayakamee S, White NJ.Simple methods for assessing quinine pre-treatment in acute malaria. Trans R Soc Trop Med Hyg 1995;89:665-667.
344. Smith MD, Suputtamongkol Y, Chaowagul W, Assicot M, Bohuon C, Petitjean S, White NJ.Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 1995;20:641-643.
345. Smith MD, Wuthiekanun V, Walsh AL, Teerawattanasook N, Desakorn V, Suputtamongkol Y, Pitt TL, White NJ.Latex agglutination for rapid detection of Pseudomonas pseudomallei antigen in urine of patients with melioidosis.J Clin Pathol 1995;48:174-176.
346. Smith MD, Wuthiekanun V, Walsh AL, White NJ.Quantitative recovery of Burkholderia (Pseudomonas) pseudomallei from soil in Thailand. Trans R Soc Trop Med Hyg 1995;89:488-490.
347. ter Kuile FO, Luxemburger C, Nosten F, Phaipun L, Chongsuphajaisiddhi T, White NJ. Predictors of mefloquine treatment failure: a prospective study in 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:660-664.
348. ter Kuile FO, Nosten F, Luxemburger C Kyle D, Teja-Isavadharm P, Phaipun L, Price RN, Chongsuphajaisiddhi T, White NJ.Mefloquine treatment of acute falciparum malaria: A prospective study of non-serious adverse effects in 3673 patients. Bull WHO 1995;73:631-642.
349. Udomsangpetch R, Thanikkul K, Pukrittayakamee S, White NJ.Rosette formation by Plasmodium vivax. Trans R Soc Trop Med Hyg 1995;89:635-637.
350. Waller D, Krishna S, Crawley J, Miller K, Nosten F, Chapman D, ter Kuile FO, Craddock C, Berry C, Holloway PAH, Brewster D, Greenwood BM, White NJ.Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995;21:577-587.
351. Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Chaowagul W, Dance DAB, Angus B, White NJ.Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis 1995;21:1498-1500.
352. Walsh AL, Smith MD, Wuthiekanun V, White NJ.Post antibiotic effects and Burkholderia (Pseudomonas) pseudomallei: an evaluation of current treatment. Antimicrob Agents Chemother 1995;39:2356-2358.
353. Walsh AL, Wuthiekanun V, Smith MD, Suputtamongkol Y, White NJ.Selective broths for the isolation of Pseudomonas pseudomallei from clinical samples. Trans R Soc Trop Med Hyg 1995;89:124.
354. White NJ.Controversies in the management of severe falciparum malaria. Bailliere's Clinical Infectious Diseases. 2: ed G. Pasvol. Balliere Tindall.London. 1995;309-330.
355. White NJ, Jong EC. Malaria diagnosis and treatment. In: Jong EC, McMullen R eds. The Travel and Tropical Medicine Manual. 2nd edition. Philadelphia: WB Saunders, 1995;189-202.
356. White NJ.Optimal regimens of parenteral quinine.Trans R Soc Trop Med Hyg 1995;89:462-463.
357. Wuthiekanun V, Smith MD, Dance DAB, White NJ.Isolation of Pseudomonas pseudomallei from soil in north eastern Thailand. Trans R Soc Trop Med Hyg 1995;89:41-43.
358. Wuthiekanun V, Smith MD, White NJ.Survival of Burkholderia pseudomallei in the absence of nutrients. Trans R Soc Trop Med Hyg 1995;89:491.
359. Angus BJ, Thanikkul K, Silamut K, White NJ, Udomsangpetch R.Rosette formation in Plasmodium ovale infection. Am J Trop Med Hyg 1996;55:560-561.
360. Aronson JK, White NJ.Principles of clinical pharmacology and drug therapy.In: Oxford Textbook of Medicine, 3rd Edition; Ed. Weatherall, DJ, Ledingham, JGG, Warrell, DA.Oxford University Press, Oxford. 1996; pp1235-1264.
361. Davis TME, Benn JJ, Suputtamongkol Y, Weinberg J, Umpleby AM, Chierakul N, White NJ.Lactate turnover and forearm lactate metabolism in severe falciparum malaria. Endocrinol Metabol 1996;3:105-115.
362. Krishna S, White NJ.Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.Clin Pharmacokinet 1996;30:263-299.
363. Krishna S, Supanaranond W, Pukrittayakamee S, ter Kuile F, Ruprah M, White NJ.The disposition and effects of two doses of dichloroacetate in adults with severe falciparum malaria. Brit J Clin Pharmacol 1996;41:29-34.
364. Luxemburger C, Kyaw Ley Thew, White NJ, Webster HK, Kyle DE, Maelankirri L, Chongsuphajaisiddhi T, Nosten F.The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 1996;90:105-111.
365. Luxemburger C, Price RN, Nosten F, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Mefloquine in infants and young children. Ann Trop Paediatr, 1996;16:281-286.
366. Nontprasert A, Pukrittayakamee S, Kyle DE, Vanijanonta S, White NJ.Antimalarial activity and interactions between quinine, dihydroquinine, and 3-hydroxyquinine against P. falciparum in vitro. Trans R Soc Trop Med Hyg 1996;90:553-555.
367. Nosten F, Luxemburger C, Kyle DE, Ballou WR, Wittes J, Heh Wah, Chongsuphajaisiddhi T, Gordon DM, White NJ, Sadoff JC, Heppner DG.Randomised double-blind placebo-controlled efficacy trial of the SPf66 vaccine against falciparum malaria in children in north-western Thailand. Lancet 1996;348:701-707.
368. Nosten F, van Vugt M. Malaria: still no vaccine and very few drugs. Curr Opin Infect Dis 1996; 9: 429-434.
369. Price RN, Nosten F, Luxemburger C, ter Kuile F, Paiphun L, Chongsuphajaisiddhi T, White NJ.The effects of artemisinin derivatives on malaria transmissability. Lancet 1996; 347: 1654-1658.
370. Smith MD, Wuthiekanun V, Walsh AL , White NJ.In-vitro activity of carbapenem antibiotics against B-lactam susceptible and resistant strains of Burkholderia pseudomallei.J Antimicrob Chemother 1996; 37: 611-615.
371. Teja-Isavadharm P, Nosten F, Kyle DE, Luxemburger C, ter Kuile F, Peggins JO, Brewer T, White NJ.Comparative bio-availability of oral, rectal and intramuscular artemether in healthy subjects-use of simultaneous measurement by high performance liquid chromatography with electrochemical detection and bioassay.Brit J Clin Pharmacol 1996: 42: 599-604.
372. Udomsangpetch R, Pipitaporn B, Krishna S, Angus B, Pukrittayakamee S, Bates I, Suputtamongkol Y, Kyle DE, White NJ.Antimalarial drugs reduce cytoadherence and rosetting of Plasmodium falciparum.J Infect Dis 1996;173: 691-698.
373. Udomsangpetch R, Taylor BJ, Looareesuwan S, White NJ, Elliott JF, Ho M.Receptor specificity of clinical Plasmodium falciparum isolates: nonadherence to cell-bound E-selectin and vascular cell adhesion molecule-1. Blood 1996;88:2754-2760.
374. Vanijanonta S, Chantra A, Phophak N, Chindanond D, Clemens R, Pukrittayakamee S. Therapeutic effects of chloroquine in combination with quinine in uncomplicated falciparum malaria. Ann Trop Med Parasitol 1996;90:269-275.
375. Viravan C, Dance DA, Looareesuwan S, Ariyarit C, Wattanagoon Y, Davis TME, Wuthiekanun V, Tantivanich S, Angus BJ, White NJ.A prostective clinical and bacteriologic study of inguinal buboes in Thai men. Clin Infect Dis 1996;22:233-239.
376. Walsh AL, Wuthiekanun V.The laboratory diagnosis of melioidosis. Br J Biomed Sci 1996;53:249-253.
377. White NJ, Olliaro PL.Rationale for combination therapy for malaria. Parasitology
Today 1996;12:399-401.
378. White NJ.What future is there for the treatment of tropical diseases? Ramathibodi Medical Journal 1996;19:73-78.
379. White NJ.The treatment of malaria.N Eng J Med 1996;335:800-806.
380. White NJ.Can amodiaquine be resurrected? (Commentary). Lancet 1996;335:1184-85.
381. White NJ. Malaria.In GC Cook ed: Manson's Tropical Diseases. 20th edition.London: WB Saunders, 1996;1087-1164.
382. Wuthiekanun V, Smith MD, Dance DAB, Walsh AL, Pitt TL, White NJ.Biochemicalcharacteristics of clinical and environmental isolates of Burkholderia pseudomallei.J Med Microbiol 1996;45:408-412.
383. Acharya GP, Davis TME, Ho M, Harris S, Chataut C, Acharya S, Tuhladar N, Kafle KE, Pokhrel B, Nosten F, Dance DAB, Smith A, Weber A, White NJ. Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever. J Antimicrob Chemother, 1997; 40:91-98.
384. Angus B, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red cells without their destruction in acute falciparum malaria. Blood, 1997; 90:2037-2040.
385. Chaowagul W, Suputtamongkol Y, Smith MD, White NJ. Oral fluoroquinolones for maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg, 1997; 91:599-601.
386. Desakorn V, Silamut K, Angus B, Sahassananda D, Chotivanich K, Suntharasamai P, Simpson J, White NJ. Semi-Quantitative measurement of Plasmodium falciparum PfHRP2 in blood and plasma. Trans R Soc Trop Med Hyg, 1997; 91:479-483.
387. Dondorp AM, Angus BJ, Hardeman MR, Chotivanich K, Silamut K, Ruangveerayuth R, White NJ, Vreeken J. Prognostic significance of reduced red cell deformability in severe falciparum malaria. Am J Trop Med Hyg, 1997; 57:507-511.
388. Luxemburger C, Ricci F, Nosten F, Raimond D, Saw Bathet, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Trans R Soc Trop Med Hyg, 1997; 91:256-262.
389. Ho M, Schollaardt T, Smith MD, Perry MB, Brett PJ, Chaowagul W, Bryan LE. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun, 1997; 65:3648-3653.
390. Nosten F, Luxemburger C, Kyle DE, Gordon DM, Ballou WR, Sadoff JC, Brockman A, Permpanich B, Chongsuphajaisiddhi T, Heppner DG. Phase I trial of the SPF66 malaria vaccine in a malaria-experienced population in South East Asia. Am J Trop Med Hyg, 1997; 56:526-532.
391. Price R, Robinson G, Brockman A, Cowman A, Krishna S. Assessment of Pfmdr 1 gene copy number by tandem competitive polymerase chain reaction. Mol Biochem Parasitol, 1997; 85:161-169.
392. Price RN, Nosten F, Luxemburger C, van Vugt M, Paiphun L, Chongsuphajaisiddhi T, White NJ. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg, 1997; 91:574-577.
393. Pukrittayakamee S, Looareesuwan S, Keeratithakul D, Davis TME, Teja-Isavadharm P, Nagachinta B, Weber A, Smith AL, Kyle D, White NJ. A study of the factors affecting the metabolic clearance ofquinine in malaria. Eur J Clin Pharmacol, 1997; 52:487-493.
394. Smithuis FM, Monti F, Grundi M, Zaw Oo A, Kyaw TT, Phe O, White NJ. In vivo sensitivity of Plasmodium falciparum to chloroquine, sulphadoxine- pyrimethamine, and mefloquine in Rakhine State, Western Myanmar. Trans R Soc Trop Med Hyg, 1997; 91:468-472.
395. Smith MD, Angus B, Wuthiekanun V, White NJ. Arabinose assimilation defines a non-virulent biotype of Burkholderia pseudomallei. Infect Immun, 1997; 65:4319-4321.
396. Supanaranond W, Suputtamongkol Y, Davis TME, Pukrittayakamee S, Teja-Isavadharm P, Webster HK, White NJ. Lack of a significant adverse cardiovascular effect of combined quinine and mefloquine therapy for uncomplicated malaria. Trans R Soc Trop Med Hyg, 1997; 91:694-696.
397. Sura T, Krishna S, Smith MD, White NJ. Polymerase chain reaction for the detection of Burkholderia pseudomallei. Diag Microbiol Infect Dis, 1997; 29:121-127.
398. Thomson, J. K., Rubio, J. P., Curuana, S., Brockman, A., Wickham, M. E. & Cowman, A. F. The chromosomal organization of the Plasmodium falciparum var gene family is conserved. Molecular and Biochemical Parasitology, 1997: 49-60.
399. Trakulsomboon S, Dance DAB, Smith MD, White NJ, Pitt TL. Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol, 1997; 46:565-570
400. White NJ. Assessment of the pharmacodynamic properties of the antimalarial drugs in vivo. Antimicrob Agents Chemother, 1997; 41:1413-1422.
401. White NJ. Practice of clinical medicine in the tropics. Lancet, 1997; 349 (suppl lll): 6-8.
402. White NJ. Malaria. In Antibiotics and Chemotherapy, 7th Edition. Eds FO Grady, HP Lambert, RG Finch, D Greenwood. Churchill-Livingstone. Edinburgh, 1997; 896-906.
403. Wilairatana P, Kyle DE, Looareesuwan S, Chinwongprom K, Amradee S, White NJ, Watkins WM. Poor efficacy of antimalarial biguanide-dapsone combinations in the treatment of acute, uncomplicated, falciparum malaria in Thailand. Ann Trop Med Parasitol, 1997; 91:2:125-132.
404. Austin DJ, White NJ, Anderson RM. The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. J Theoret Biol, 1998; 194:313-39.
405. Anuntagool N, Intachote P, Wuthiekanun V, White NJ, Sirisinha S. Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates. Clin Diag Lab Immunol, 1998; 5:225-229.
406. Chotivanich KT, Udomsangpetch R, Pipitaporn B, Angus B, Suputtamongkol Y, Pukrittayakamee S, White NJ. Rosetting characteristics of uninfected erythrocytes from healthy individuals and malaria patients. Ann Trop Med Parasitol, 1998; 92:45-56.
407. Chotivanich KT, Pukrittayakamee S, Simpson J, White NJ, Udomsangpetch R. Characteristics of P. vivax-infected erythrocyte rosettes. Am J Trop Med Hyg, 1998; 59:73-76.
408. Chotivanich KT, Simpson J, White NJ. Estimating Plasmodium vivax parasitaemia. Trans R Soc Trop Med Hyg, 1998; 92:176.
409. Dondorp AM, De Bel PEE, Angus BJ, Chotivanich KT, Silamut K, Romijn JA, Ruangveerayuth R, Hoek FJ, Kager PA, Vreeken J, White NJ. Nitric oxides in plasma, urine, and cerebrospinal fluid in patients with severe falciparum malaria. Am J Trop Med Hyg, 1998; 59:497-502.
410. Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature, 1998; 395:851-852.
411. Ho M, Schollaardt T, Snape S, Looareesuwan S, Suntharasamai P, White NJ. Endogenous IL-10 modulates proinflammatory response in Plasmodium falciparum malaria. J Infect Dis, 1998; 178:520-5.
412. Ho M, Schollaardt T, Nui X, Looareesuwan S, Patel KD, Kubes P. Characterisation of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions. Blood, 1998; 91:4803-4809.
413. Hoontrakoon S, Suputtamongkol Y. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. Trop Med Intl Hlth, 1998; 3:156-161.
414. Lindsay SW, Ewald JA, Samung Y, Apiwathnasorn C, Nosten F. Thanaka (Limonia acidissima) and deet (di-methyl benzamide) mixture as a mosquito repellent for use by Karen women. Med Vet Entomol, 1998; 12:295-301.
415. Looareesuwan S, Olliaro P, White NJ, Chongsuphajaisiddhi T, Sabcharoen A, Thimasarn K, Nosten F, Singhasivanon P, Supavej S, Khunsmith S, Wylings S, Kanyok T, Walsh D, Leggat PA, Doberstyn EB. Consensus recommendation on the treatment of malaria in Southeast Asia. SE Asian J Trop Med Publ Hlth, 1998; 29:355-360.
416. Luxemburger C, Nosten F, Kyle DE, Khiricharoen L, Chongsuphajaisiddhi T, White NJ. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg, 1998; 92:45-49.
417. Luxemburger C, Rigal J, Nosten F. Health care in refugee camps. Trans R Soc Trop Med Hyg, 1998; 92:129-130.
418. Luxemburger C, van Vugt M, Slight T, Price RN, Chongsuphajaisiddhi T, Chantavanich P, White NJ, Nosten F. Early vomiting of mefloquine in children with uncomplicated falciparum malaria is not modified by the timing of antipyretic treatment. Trans R Soc Trop Med Hyg, 1998; 92:562-563.
419. Luxemburger C, Brockman A, Silamut K, Nosten F, van Vugt M, Gimenez F, Chongsuphajaisiddhi T, White NJ. Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans R Soc Trop Med Hyg, 1998; 92:668-669.
420. McGready R, Cho Thein, Cho Ju Ju, Simpson J, Luxemburger C, Dubowitz L, Looareesuwan S, White NJ, Nosten F. Artemisinin derivatives in the treatment of malaria in pregnancy. Trans R Soc Trop Med Hyg, 1998; 92:430-433.
421. McGready R, Cho T, Hkirijaroen L, Simpson J, Chongsuphajaisiddhi T, White NJ, Nosten F. Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy. Ann Trop Med Parasitol, 1998; 92:643-653.
422. McGready R, Simpson J, White NJ, Nosten F, Lindsay SW. Smoking cheroots reduces birthweight. Lancet 1998; 352:1521-1522.
423. Nosten F, Hien TT, White NJ. Use of artemisinin derivatives for the control of malaria. Medecine Tropicale, 1998; 58 (Suppl 3):45-49.
424. Nosten F, van Vugt M, White NJ. Intra-rectal artemisinin derivatives. Medicine Tropicale, 1998; 58 (Suppl 3):63-64.
425. Nontprasert A, Nosten-Bertrand M, Pukrittayakamee S, Vanijanonta S, Angus BJ, White NJ. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am J Trop Med Hyg, 1998; 59:519-522.
426. Paul REL, Hackford I, Brockman A, Muller-Graf C, Price R, Luxemburger C, White NJ, Nosten F, Day K P. Transmission intensity and Plasmodium falciparum diversity on the north western border of Thailand. Am J Trop Med Hyg, 1998; 58:195-203.
427. Price RN, Luxemburger C, van Vugt M, Nosten F, Am Kham, Simpson J, Looareesuwan S, Chongsuphajaisiddhi T, White NJ. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria. Trans R Soc Trop Med Hyg, 1998; 92:207-211.
428. Price R, Nosten F, White NJ. Prolongation of the QTc interval in African children treated for falciparum malaria. Am J Trop Med Hyg, 1998; 59:503.
429. Price RN, van Vugt M, Nosten F, Luxemburger C, Brockman A, Phaipun L, Chongsuphajaisiddhi T, White NJ. Artesunate versus artemether for the treatment of recrudescent multi-drug resistant falciparum malaria. Am J Trop Med Hyg, 1998; 59:883-888.
430. Pukrittayakamee S, Chantra A, Vanijanonta S, White NJ. Pulmonary oedema in vivax malaria. Trans R Soc Trop Med Hyg, 1998; 92:421-422.
431. Sirisinha S, Anuntagool N, Intachote P, Wuthiekanun V, Puthucheary SD, Vadivelu J, White NJ. Antigenic differences between clinical and environmental isolates of Burkholderia pseudomallei. Microbiol Immunol, 1998; 42:731-737.
432. Thomson J, Rubio J, Caruana S, Brockman A, Cowman A. The chromosomal organisation of the Plasmodium var gene family is conserved. Mol Biochem Parasitol, 1998; 87:49-60.
433. van Vugt M, Brockman A, Gemperli B, Luxemburger C, Gathman I, Royce C, Slight T, Looareesuwan S, White NJ, Nosten F. Randomised comparison of artemether-benflumetol and artesunate-mefloquine in the treatment of multi-drug resistant falciparum malaria. Antimicrob Agents Chemother, 1998; 42:135-139.
434. van Vugt M, Ezzet F, Phaipun L, Nosten F, White NJ. The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol). Trans R Soc Trop Med Hyg, 1998; 92:564-565.
435. White NJ. Malaria pathophysiology. In I Sherman, ed. Malaria: parasite biology pathogenesis, protection. ASM press, 1998; 371-385.
436. White NJ. Why is it that antimalarial drugs do not always work? Ann Trop Med Parasitol, 1998; 92:449-458.
437. White NJ. Drug resistance in malaria. Brit Med Bull, 1998; 54:703-715.
438. White NJ. Preventing antimalarial drug resistance through combinations. Drug Res Updates, 1998; 1:3-9.
439. White NJ. Qinghaosu in combinations. Médecine Tropicale, 1998; 58:85-88.
440. White NJ, Olliaro P. Artemisinin and derivatives in the treatment of uncomplicated malaria. Médecine Tropicale, 1998; 58 (Suppl 3):63-64.
441. White NJ, Breman JG. Malaria and other diseases caused by red blood cell parasites. In: Fauci AS, Martin JB, Braunwald E, Kasper DL, Isselbacher KJ, Hauser SL, Wilson JD, Longo DL eds. Harrison's Principles of Internal Medicine. 14th edition. New York: McGraw-Hill Inc., 1998; 1180-1189.
442. White NJ. Not much progress in treatment of cerebral malaria (editorial). Lancet, 1998; 352:594-5
443. Brockman A, Paul REL, Anderson TJC, Hackford I, Phaiphun L, Looareesuwan S, Nosten F, Day KP. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg, 1999; 60:14-21.
444. Chaiyaroj SC, Kotrnon K, Koonpaew S, Anantagool N, White NJ, Sirisinha S. Differences in genomic macrorestriction patterns of arabinose-positive (Burkholderia thailandensis) and arabinose-negative Burkholderia pseudomallei. Microbiol Immunol, 1999; 43:625-30.
445. Chaowagul W, Simpson A J H, Suputtamongkol Y, Smith MD, Angus BJ, White NJ. A comparison of chloramphenicol, trimethoprim-sulfamethoxazole and doxycycline versus doxycycline alone in the maintenance treatment of melioidosis. Clin Infect Dis, 1999; 29:375-80.
446. Chaowagul W, Simpson AJH, Suputtamongkol Y, White NJ. Empirical cephalosporin treatment in melioidosis. Clin Infect Dis, 1999; 28:1328.
447. Davis TME, Pongponratn E, Supanaranond W, Pukrittayakamee S, Helliwell T, Holloway P, White NJ. Skeletal muscle involvement in falciparum malaria: biochemical and ultrastructural study. Clin Infect Dis, 1999; 29:831-835.
448. Desakorn V, Smith MD, Walsh AL, Simpson AJH, Sahassanada D, Rajanuwong A, Wuthiekanun V, Howe PA, Angus BJ, Suntharasamai P, White NJ. Diagnosis of Penicillium marneffei infection by quantitation of urinary antigen using an enzyme immunoassay. J Clin Micro, 1999; 37:117-121.
449. Dondorp AM, Angus BJ, Chotivanich K, Silamut K, Ruangveerayuth R,Hardeman MR, Kager PA, Vreeken J, White NJ. Red cell deformability as a predictor of anemia in severe falciparum malaria. Am J Trop Med Hyg, 1999; 60:733-737.
450. Dondorp AM, Chotivanich K, Fucharoen S, Silamut K, Vreeken J, Kager PA, White NJ. Red cell deformability, splenic function and anaemia in thalassaemia. Brit J Haematol, 1999; 105:505-508.
451. Ho M, White NJ. Molecular mechanisms of cytoadherence in malaria. Am J Physiol, 1999; 276:C1231-1242.
452. Krishna S, Taylor AM, Supanaranond W, Pukrittayakamee S, ter Kuile F, Tawfiq KM, Holloway PAH, White NJ. Thiamine deficiency complicates malaria in Southeast Asian adults. Lancet, 1999; 353:546-549.
453. Lauw FN, Simpson AJH, Prins JM, Smith MD, Kurimoto M, van Deventer SJH, Speelman P, Chaowagul W, White NJ, van der Poll T. Elevated plasma concentrations of Interferon-g (IFN-g) and the IFN-g-inducing cytokines Interleukin-18 (IL-18), IL-12 and IL-15 in severe melioidosis. J Infect Dis, 1999; 180:1878-1885.
454. Lewallen S, Harding SP, Ajewole J, Schulenburg WE, Molyneux ME, Marsh K, Usen S, White NJ, Taylor TE. A review of the spectrum of clinical fundus findings in P falciparum malaria in African children with a proposed classification and grading. Trans R Soc Trop Med Hyg, 1999; 93: 619-622.
455. Luxemburger C, van Vugt M, Jonathan S, McGready R, Looareesuwan S, White NJ, Nosten F. Treatment of vivax malaria in an endemic area on the western border of Thailand. Trans R Soc Trop Med Hyg, 1999, 93:433-438.
456. Luxemburger C, Nosten F, White NJ Naturally acquired immunity to vivax malaria. (letter) Lancet, 1999; 354:162.
457. Looareesuwan S, Wilairatana P, Krudsood S, Treeprasertsuk S, Singhasivanon P, Bussaratid V, Chokjindachai W, Viriyavejakul P, Chalermrut K, Walsh DS, White NJ. Chloroquine sensitivity of Plasmodium vivax in Thailand. Ann Trop Med Parasitol, 1999; 93:225-230.
458. McGready R. Meet my uncle (foetus papyraceus). Lancet, 1999; 353:414.
459. McGready R, Nosten F. The Thai-Burmese border: drug studies of Plasmodium falciparum in pregnancy. Ann Trop Med Parasitol, 1999; 93 Supplement 1:S19-S23.
460. Newton P, Keeratithakul D, Teja-Isavadharm P, Pukrittayakamee S, Kyle D, White NJ. Pharmacokinetics of quinine and 3-hydroxyquinine in severe falciparum malaria with acute renal failure. Trans R Soc Trop Med Hyg, 1999; 93:69-72.
461. Newton P, White NJ. Malaria: New developments in treatment and prevention. Ann Rev Med, 1999; 50:179-92.
462. Nosten F, Vincenti M, Simpson JA, Yei P, Kyaw Lay Thwai, de Vries A, Chongsuphajaisiddhi T, White NJ. The effects of mefloquine treatment in pregnancy. Clin Infect Dis, 1999; 28:808-815.
463. Nosten F, van Vugt M. Neuropsychiatric adverse effects of mefloquine (What do we know and what should we do?). CNS Drugs, 1999; 11:1-8.
464. Nosten F,McGready R,Simpson JA,Thwai KL,Balkan S,Cho T,Hkirijaroen L,Looareesuwan S,
White NJ. The effects of Plasmodium vivax malaria in pregnancy. Lancet, 1999; 354:546-549.
465. Pham YT, Nosten F, Farinotti R, White NJ, Gimenez F. Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria. Int J Clin Pharmacol Therap, 1999; 37:58-61.
466. Price RN, Nosten F, Luxemburger C, Phaipun L, ter Kuile F, van Vugt M, Chongsuphajaisiddhi T, White NJ. Risk factors for gametocyte carriage in uncomplicated falciparum malaria. Am J Trop Med Hyg, 1999; 60:1019-1023.
467. Price RN, Simpson JA, Teja-Isavatharm P, Myint Myint Than, Luxemburger C, Heppner G, Chongsuphajaisiddhi T, Nosten F, White NJ. Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob Agents Chemother, 1999; 43:341-346.
468. Price RN, van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, ter Kuile FO, Am Kham, Chongsuphajaisiddhi T, White NJ, Nosten F. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg, 1999; 60:547-555.
469. Price RN, Cassar C, Brockman A, Duraisingh M, van Vugt M, White NJ, Nosten F, Krishna S. The pfmdr1 gene is associated with a multidrug resistance phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob Agents Chemother, 1999; 43:2943-2949.
470. Silamut K, Phu NH, Whitty C, Turner GDH, Louwrier K, Mai NTH, Simpson J, Hien TT, White NJ. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Path, 1999; 155:395-410.
471. Simpson AJH, White NJ. Combination antibiotic therapy for severe melioidosis. Clin Infect Dis, 1999; 28:410.
472. Simpson AJH, White NJ. Burkholderia species: Melioidosis and glanders. In V. Yu, TC Merigan, SL Barriere eds. Antimicrobial Chemotherapy and Vaccines. Williams & Wilkins, Baltimore, 1999; 94-97.
473. Simpson AJH, Suputtamongkol Y, Smith MD, Angus BJ, Rajanuwong A, Wuthiekanun V, Howe PA, Walsh AL, Chaowagul W, White NJ. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis, 1999; 29:381-7.
474. Simpson AJH, Howe PA, Wuthiekanun V, White NJ. A comparison of lysis-centrifugation, pour plate and conventional blood culture methods in the diagnosis of septicaemic melioidosis. J Clin Pathol, 1999; 52:616-619.
475. Simpson AJH, White NJ, Wuthiekanun V. Aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother, 1999; 43:2332.
476. Simpson JA, Silamut K, Chotivanich K, Pukrittayakamee S, White NJ. Red cell selectivity in malaria: a study of multiple infected erythrocytes. Trans R Soc Trop Med Hyg, 1999; 93:165-168.
477. Simpson JA, Price RN, ter Kuile FO, Teja-Isvadharm P, Nosten F, Aarons L, White NJ. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmac Ther, 1999; 66:472-484.
478. Steinmetz I, Reganzerowski A, Brenneke B, Häußler S, Simpson A, White NJ. Rapid identification of Burkholderia pseudomallei by latex agglutination based on an exopolysaccharide-specific monoclonal antibody. J Clin Microbiol, 1999; 37:225-228.
479. Suputamongkol Y, Chaowagul W, Chetchotisakd P, Lertpatanasuwun N, Intaranongpai S, Ruchutrakool T, Budhsarawong D, Mootsikapun P, Wuthiekanun W, Teerawatasook N, Lulitanond A. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis, 199; 29:408-413.
480. van Vugt M, Wilairatana P, Gemperli B, Gathmann I, Phaipun L, Brockman A, Luxemburger C, White NJ, Nosten F, Looareesuwan S. Efficacy of six doses or artemether-benflumetol in the treatment of multi-drug resistant falciparum malaria. Am J Trop Med Hyg, 1999; 60:936-942.
481. van Vugt M, White NJ. The treatment of chloroquine-resistant malaria. Tropical Doctor, 1999; 29:176-179.
482. van Vugt M, Edstein MD, Proux S, Kyaw Lay, Ooh Mya, Looareesuwan S, White NJ, Nosten F. Absence of an interaction between artesunate and atovaquone-proguanil. Eur J Clin Pharmac, 1999; 55:469-474.
483. van Vugt M, Ezzet F, Nosten F, White NJ. No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine. Am J Trop Med Hyg, 1999; 61:964-967.
484. White NJ. Cerebral perfusion in cerebral malaria (editorial). Crit Care Med,1999; 27:478-479.
485. White NJ. Antimalarial drug resistance and mortality in falciparum malaria. Trop Med Intl Hlth; 1999; 4:469-470.
486. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia, 1999; 41:301-308.
487. White NJ. Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc Lond B, 1999; 354:739-749.
488. White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet, 1999; 37:105-125.
489. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor T, Newbold CI, Ruebush II TK, Danis M, Greenwood BM, Anderson RM, Olliaro P. Averting a malaria disaster. Lancet, 1999; 353:1965-1967
490. White NJ. Variation in virulence of dengue virus. Lancet, 1999; 354:1401-2.
491. White NJ. What is the future of exchange transfusion in severe malaria? J Infect 1999; 39:185-186.
492. White N.J. The fruits of obsession. Review of "The beast in the mosquito", the correspondence between Ronald Ross and Patrick Manson. Lancet, 1999; 354:519-520.
493. Wajanarogana S, Sonthayanon P, Wuthiekanun V, Panyim S, Simpson AJ, Tungpradabkul S. Stable marker on flagellin gene sequences related to arabinose non-assimilating pathogenic Burkholderiapseudomallei. Microbiol Immunol, 1999; 43:995-1001.
494. Wuthiekanun V, Howe PA, Simpson AJH, Smith MD, Walsh AL, Angus BJ, Rajchanuwong A, White NJ. Antifungal susceptibilities of Cryptococcus neoformans in Northeast Thailand. Trans R Soc Trop Med Hyg, 1999; 93:96-97.
